1. The Plaintiff (Counterclaim Defendant)’s hospitalization medical expenses based on the insurance contract indicated in the attached list.

A principal lawsuit and counterclaim shall also be deemed a principal lawsuit and counterclaim.

1. Facts of recognition;

A. On March 28, 2012, the Plaintiff entered into an insurance contract that covers hospitalization, medical expenses, etc. as stated in the attached list with the Defendant, and the major content of the said insurance contract’s terms and conditions of the indemnity medical expenses clause (hereinafter “instant special terms and conditions”) are as follows.

[3] The amount equivalent to 90% of the total sum of the subscription amount per disease (50 million won by the contractor as the maximum of the subscription amount, hospitalization expenses, hospitalization expenses, and hospitalization surgery expenses stipulated in the National Health Insurance Act, and the amount of non-benefit (excluding the difference of injury and disease compensation expenses) among the medical care benefits or medical care expenses stipulated in the National Health Insurance Act (excluding the difference of injury and disease compensation expenses) (Provided, That if the amount equivalent to 10% exceeds two million won per year from the date when the contract is entered into or every year, the excess amount shall be compensated as follows:

) In the case of hospitalization, the difference between the difference between the difference between the actual user’s room and the standard sick room, less than 50% of the difference between the actual user’s room and the standard sick room (However, the average daily amount shall be limited to 100,000 won per day, and the average daily amount shall be calculated by dividing the difference between the average per day’s

(C) to the extent of the amounts determined, D.C.

[Non-compensationed Matters] (3) Hospital hospitalization (3) Company shall not compensate for the following hospital medical expenses:

4. Health examinations, vaccinations, and artificial heritage: Provided, That where it is for the purpose of treating diseases covered by the company, it shall be covered by compensation;

5. Expenses incurred in nutritional agents, comprehensive non-human agents, Bomon medication, universal credit medication, diagnosis for confirmation of friendly parents, infertility tests, infertility surgery, infertility surgery, infertility surgery, assisted reproductive technology (including internal and extra-human artificial insemination), and expenses related to growth promotion: Provided, That the disease covered by the company shall be covered;